ImmuCell Corporation Accounts Payable
ImmuCell Corporation (ICCC) had Accounts Payable of $241.02 thousand as of 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2014-11-12
- 2014-09-30: Accounts Payable, Current $241.02K.
- 2014-06-30: Accounts Payable, Current $148.33K.
- 2014-03-31: Accounts Payable, Current $366.01K.
- 2013-12-31: Accounts Payable, Current $152.15K.
| Period end | Accounts Payable, Current |
|---|---|
| 2014-09-30 | $241.02K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $148.33K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $366.01K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $152.15K 10-Q · filed 2014-11-12 |
| 2013-09-30 | $166.28K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $171.45K 10-Q · filed 2013-08-13 |
| 2013-03-31 | $168.56K 10-Q · filed 2013-05-14 |
| 2012-12-31 | $228.71K 10-K · filed 2014-03-26 |
| 2012-09-30 | $165.25K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $112.45K 10-Q/A · filed 2012-09-07 |
| 2012-03-31 | $219.61K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $149.88K 10-K · filed 2013-03-28 |
| 2011-09-30 | $96.41K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $58.48K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $105.74K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |